Partnership Supports Upsher-Smith’s Commitment to Expanding its Portfolio of Products through Strategic Partnerships
Maple Grove, MN – July 29, 2022 — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has entered into an exclusive agreement with Emphascience, Inc. (Emphascience) to support the development of a specialty branded generic product. This collaboration is part of Upsher-Smith’s company-wide effort to grow the Company’s portfolio of products through strategic partnerships and product acquisitions.
Under the terms of the agreement, Emphascience will develop the product exclusively for Upsher-Smith. Upsher-Smith will manufacture, market and distribute it under its own label in the U.S. upon FDA approval. Financial terms related to the deal have not been disclosed.
“Upsher-Smith is committed to growing its ANDA portfolio through external programs and strategic partnerships that will drive volume to our new manufacturing facility,” said Rich Fisher, President and COO, Upsher-Smith. “We look forward to working with Emphascience, a company that is well known for its development expertise as we continue to expand our portfolio with high-touch generic products that could fill unmet patient needs.”
Rebanta Bandyopadhyay, Ph.D., President and CEO of Emphascience added, “We are excited to partner with such a well-regarded, trusted, quality-conscious, and patient-focused pharmaceutical company as Upsher-Smith Laboratories, to apply our technical skills and scientific acumen in designing and developing high quality, innovative medicines that truly impact patients’ lives.”
Upsher-Smith will open its world-class manufacturing facility in Maple Grove, MN later this year. The new, 270,000 square foot facility will have fully up-to-date serialization and packaging capabilities and has capacity and capabilities that can support contract manufacturing for third parties. To learn more, visit www.upsher-smith.com.
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that strives to improve the health and lives of patients through an unwavering commitment to high-quality products and sustainable growth. The company brings brands and generics to a wide array of customers, always backed by its attentive level of service, strong industry relationships, and dedication to consistent product supply. For more information, visit www.upsher-smith.com.
Emphascience, Inc. is a private pharmaceutical company, focused on developing novel formulations of proven drug products to address unmet medical needs in the treatment of pain, cancer, infections, and many fatal and debilitating diseases. For more information, visit www.emphascience.com.